Next-Generation Drug-Eluting Stent Market Size, Share, Trends & Analysis By Type, Regional Outlook, Industry Insights, Key Players, Applications And Forecast To 2028

Report Summary

Eternity Insights has published a new study on Global Next-Generation Drug-Eluting Stent Market focusing on key segments as by Type (Cobalt Chromium, Stainless Steel, Others), by Application (Hospitals, Clinics, Ambulatory Surgical Centers, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Next-Generation Drug-Eluting Stent Market.

The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.

Next-Generation Drug-Eluting Stent Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Global Next-Generation Drug-Eluting Stent Market Size, 2018-2028 (USD Million)

To learn more about this report

Request For Sample

Global Next-Generation Drug-Eluting Stent Market Segmentation:

Next-Generation Drug-Eluting Stent Market, By Type

• Cobalt Chromium
• Stainless Steel
• Others

Next-Generation Drug-Eluting Stent Market, By Application

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Other

To learn more about this report

Request For Sample

Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Next-Generation Drug-Eluting Stent market in terms of demand generation. The Next-Generation Drug-Eluting Stent market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Next-Generation Drug-Eluting Stent market for below listed coun-tries across each region.

North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).

Global Next-Generation Drug-Eluting Stent Market Taxonomy:

To learn more about this report

Request For Sample

Global Next-Generation Drug-Eluting Stent Market Competitive Landscape

The global Next-Generation Drug-Eluting Stent market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details

• Company Overview
• Financial Analysis
• Product Portfolio Analysis
• Strategic Overview
• SWOT Analysis

List of Companies Profiled in the report:

• Abbott
• Biosensors International
• Medtronic
• Sorin Group
• SMT
• Terumo
• Other Players of Specific Interest can be added based on requirement

Market Segmentation

Report Attributes	Details
The market size value in 2021	USD XX.XX Million
CAGR (2021 - 2028)	XX.XX %
The Revenue forecast in 2028	USD XX.XX Million
Base year for estimation	2021
Historical data	2018-2019
Forecast period	2022-2028
Quantitative units	Revenue in USD Million CAGR from 2021 to 2028
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	By Type Outlook, Application Outlook, Regional Outlook
By Type Outlook	Cobalt Chromium, Stainless Steel, Others
By Application Outlook	Hospitals, Clinics, Ambulatory Surgical Centers, Other
Regional scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope	U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey
Key companies profiled	Abbott, Biosensors International, Medtronic, Sorin Group, SMT, Terumo
Customization Available	Yes, the report can be tailored to meet your specific requirements.

Key Benefits to the stake holders

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come

Table Of Contents

Table of Contents

1 Study Coverage
1.1 Next-Generation Drug-Eluting Stent Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by Product
1.4.2 Cobalt Chromium
1.4.3 Stainless Steel
1.4.4 Others
1.5 Market by End User
1.5.1 Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Next-Generation Drug-Eluting Stent Market Size
2.1.1 Global Next-Generation Drug-Eluting Stent Revenue 2017-2027
2.1.2 Global Next-Generation Drug-Eluting Stent Sales 2017-2027
2.2 Next-Generation Drug-Eluting Stent Growth Rate by Regions
2.2.1 Global Next-Generation Drug-Eluting Stent Sales by Regions
2.2.2 Global Next-Generation Drug-Eluting Stent Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Next-Generation Drug-Eluting Stent Sales by Manufacturers
3.1.1 Next-Generation Drug-Eluting Stent Sales by Manufacturers
3.1.2 Next-Generation Drug-Eluting Stent Sales Market Share by Manufacturers
3.1.3 Global Next-Generation Drug-Eluting Stent Market Concentration Ratio (CR5 and HHI)
3.2 Next-Generation Drug-Eluting Stent Revenue by Manufacturers
3.2.1 Next-Generation Drug-Eluting Stent Revenue by Manufacturers (2017-2020)
3.2.2 Next-Generation Drug-Eluting Stent Revenue Share by Manufacturers (2017-2020)
3.3 Next-Generation Drug-Eluting Stent Price by Manufacturers
3.4 Next-Generation Drug-Eluting Stent Manufacturing Base Distribution, Product Types
3.4.1 Next-Generation Drug-Eluting Stent Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Next-Generation Drug-Eluting Stent Product Type
3.4.3 Date of International Manufacturers Enter into Next-Generation Drug-Eluting Stent Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Next-Generation Drug-Eluting Stent Sales by Product
4.2 Global Next-Generation Drug-Eluting Stent Revenue by Product
4.3 Next-Generation Drug-Eluting Stent Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Next-Generation Drug-Eluting Stent Breakdown Data by End User

6 North America
6.1 North America Next-Generation Drug-Eluting Stent by Countries
6.1.1 North America Next-Generation Drug-Eluting Stent Sales by Countries
6.1.2 North America Next-Generation Drug-Eluting Stent Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Next-Generation Drug-Eluting Stent by Product
6.3 North America Next-Generation Drug-Eluting Stent by End User

7 Europe
7.1 Europe Next-Generation Drug-Eluting Stent by Countries
7.1.1 Europe Next-Generation Drug-Eluting Stent Sales by Countries
7.1.2 Europe Next-Generation Drug-Eluting Stent Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Next-Generation Drug-Eluting Stent by Product
7.3 Europe Next-Generation Drug-Eluting Stent by End User

8 Asia Pacific
8.1 Asia Pacific Next-Generation Drug-Eluting Stent by Countries
8.1.1 Asia Pacific Next-Generation Drug-Eluting Stent Sales by Countries
8.1.2 Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Next-Generation Drug-Eluting Stent by Product
8.3 Asia Pacific Next-Generation Drug-Eluting Stent by End User

9 Central & South America
9.1 Central & South America Next-Generation Drug-Eluting Stent by Countries
9.1.1 Central & South America Next-Generation Drug-Eluting Stent Sales by Countries
9.1.2 Central & South America Next-Generation Drug-Eluting Stent Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Next-Generation Drug-Eluting Stent by Product
9.3 Central & South America Next-Generation Drug-Eluting Stent by End User

10 Middle East and Africa
10.1 Middle East and Africa Next-Generation Drug-Eluting Stent by Countries
10.1.1 Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Countries
10.1.2 Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Next-Generation Drug-Eluting Stent by Product
10.3 Middle East and Africa Next-Generation Drug-Eluting Stent by End User

11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Company Business Overview
11.1.3 Abbott Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Abbott Next-Generation Drug-Eluting Stent Products Offered
11.1.5 Abbott Recent Development
11.2 Biosensors International
11.2.1 Biosensors International Company Details
11.2.2 Company Business Overview
11.2.3 Biosensors International Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Biosensors International Next-Generation Drug-Eluting Stent Products Offered
11.2.5 Biosensors International Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Details
11.3.2 Company Business Overview
11.3.3 Medtronic Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Medtronic Next-Generation Drug-Eluting Stent Products Offered
11.3.5 Medtronic Recent Development
11.4 Sorin Group
11.4.1 Sorin Group Company Details
11.4.2 Company Business Overview
11.4.3 Sorin Group Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Sorin Group Next-Generation Drug-Eluting Stent Products Offered
11.4.5 Sorin Group Recent Development
11.5 SMT
11.5.1 SMT Company Details
11.5.2 Company Business Overview
11.5.3 SMT Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2020)
11.5.4 SMT Next-Generation Drug-Eluting Stent Products Offered
11.5.5 SMT Recent Development
11.6 Terumo
11.6.1 Terumo Company Details
11.6.2 Company Business Overview
11.6.3 Terumo Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Terumo Next-Generation Drug-Eluting Stent Products Offered
11.6.5 Terumo Recent Development

12 Future Forecast
12.1 Next-Generation Drug-Eluting Stent Market Forecast by Regions
12.1.1 Global Next-Generation Drug-Eluting Stent Sales Forecast by Regions 2021-2027
12.1.2 Global Next-Generation Drug-Eluting Stent Revenue Forecast by Regions 2021-2027
12.2 Next-Generation Drug-Eluting Stent Market Forecast by Product
12.2.1 Global Next-Generation Drug-Eluting Stent Sales Forecast by Product 2021-2027
12.2.2 Global Next-Generation Drug-Eluting Stent Revenue Forecast by Product 2021-2027
12.3 Next-Generation Drug-Eluting Stent Market Forecast by End User
12.4 North America Next-Generation Drug-Eluting Stent Forecast
12.5 Europe Next-Generation Drug-Eluting Stent Forecast
12.6 Asia Pacific Next-Generation Drug-Eluting Stent Forecast
12.7 Central & South America Next-Generation Drug-Eluting Stent Forecast
12.8 Middle East and Africa Next-Generation Drug-Eluting Stent Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Next-Generation Drug-Eluting Stent Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer